15-03-2023, 05:53

Theratechnologies to Present Preclinical Data at AACR

Data show that sudocetaxel zendusortide (TH1902) can induce tumor infiltrating lymphocytes and potentiate anti-PD-L1
Globe Newswire15-03-2023, 05:53
23-02-2023, 05:33

Theratechnologies Presents New Tesamorelin Data

Presentation at Conference on Retroviruses and Opportunistic Infections (CROI) demonstrates association between excess
Globe Newswire23-02-2023, 05:33
15-02-2023, 05:07

Theratechnologies to Announce Fourth Quarter and Full Year

MONTREAL, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (“Theratechnologies”), a
Globe Newswire15-02-2023, 05:07